The present and future burden of urinary bladder cancer in the world

By M. Ploeg, K. Aben, L. Kiemeney. World journal of urology, 2009

945 citations recorded by the source corpus.

Urinary bladder cancer (UBC) is a common disease worldwide. At any point in time 2.7 million people have a history of UBC. The incidence of UBC varies over the world with highest rates in developed communities. But the burden of UBC will increase in less developed areas of the world. These changes can be attributed to global changes in exposure to risk factors for UBC and growth and aging of the world population.

Subfields: Epidemiology, Oncology, Surgery

View Paper: https://www.semanticscholar.org/paper/d2fbd2f279a87d3bcb147f724e3e0b959c2d467c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. M. Burger
2. B. V. van Rhijn
3. S. Shariat
4. R. Sylvester

Citations in the corpus

• Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. (2009, background): “7 million people in the world have a history of BCa [19].”
• The global burden of urinary bladder cancer: an update (2019, background): “Moreover, we reflect on (anticipated) changes in demography and economic situation in different parts of the world and the impact these changes may have on the burden of UBC [2].”
• Epidemiology and risk factors of urothelial bladder cancer. (2013, background): “Globally, the health burden by UBC is likely to increase in the future, since rising UBC incidence rates are expected in developing countries, especially China, mainly related to the pronounced and ongoing prevalence of smoking [8].”